Excipient for Inhalation

MEGGLE’s sieved, milled and micronized alpha-lactose monyhydrate for dry powder inhalation: InhaLac® General information The delivery of active pharmaceutical ingredients...

High dose inhaled powders have received increased attention for treating lung infections. These powders can be prepared using techniques such...

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiological agent responsible for the COVID-19 pandemic, has outspread at full tilt...

Respiratory diseases are a global burden, with millions of deaths attributed to pulmonary illnesses and dysfunctions. Therapeutics have been developed,...

Spray-drying is an extensively used technology for engineering inhalable particles. Important technical hurdles are however experienced when lipid-based excipients (LBEs) are spray-dried....

The aim of the current study was to achieve a dry powder formulation of vancomycin by spray drying whilst evaluating...

The current world health threat posed by the novel coronavirus disease of 2019 (COVID-19) calls for the urgent development of effective therapeutic...

The aim of this study was to evaluate the benefits of a ternary amorphous solid dispersion (ASD) that was designed...

Ideally, inhaled therapy is driven by the needs of specific disease management. Lung biology interfaces with inhaler performance to allow...

We investigated the feasibility of preparing high-potency tacrolimus dry powder for inhalation using thin film freezing (TFF). We found that...